A pharmaceutical composition comprising an active ingredient and clavulanate wherein the clavulanate is in the form of granulated and hydrophobised particles; and intermediates in its preparation, e.g. clavulanate is granulated and/or hydrophobised form.
申请公布号
WO02083129(A3)
申请公布日期
2003.03.06
申请号
WO2002EP04062
申请日期
2002.04.11
申请人
BIOCHEMIE GESELLSCHAFT M.B.H.;DAEMON, OTTO;JENNEWEIN, HERWIG;LENTNER, THOMAS;SCHWARZ, FRANZ, XAVER;VEIGL, ROBERT
发明人
DAEMON, OTTO;JENNEWEIN, HERWIG;LENTNER, THOMAS;SCHWARZ, FRANZ, XAVER;VEIGL, ROBERT
